Jeroen Hiltermann

2025

Changes in global quality of life after treatment with immune checkpoint inhibitors in patients receiving different treatment regimens for advanced stage lung cancer in the Netherlands: a 2015-2021 cohort study

Malhotra, A., Suazo-Zepeda, E., Vinke, P. C., de Bock, G. H., Maas, W. J., Hiltermann, J. T. J. N., Rachet, B., Leyrat, C. & Quaresma, M., 20-feb.-2025, In: BMJ Open. 15, 2, 12 blz., e098062.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

23 Downloads (Pure)

Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model

Vaes, R. D. W., Cortiula, F., Lyu, S., Hiltermann, T. J. N., Houben, R., Degens, J., Hendriks, L. E. L. & Ruysscher, D. D., mei-2025, In: Lung Cancer. 203, 9 blz., 108541.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

22 Downloads (Pure)

CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis

Suazo-Zepeda, E., Viddeleer, A. R., Maas, W. J., Postmus, D., Heuvelmans, M. A., Hiltermann, T. J. N. & De Bock, G. H., jan.-2025, In: Lung Cancer. 199, 8 blz., 108054.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

28 Downloads (Pure)

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Vermeulen, O. C. B., Brouwer, E., Slart, R. H. J. A., Sandovici, M., Rutgers, A., Hilterman, T. J., Hiddinga, B., Oosting, S. F., Jalving, M., de Heij, A. H., Knapen, D. G., Hospers, G. A. P. & van der Geest, K. S. M., feb.-2025, In: Rheumatology (Oxford, England). 64, 2, blz. 771-779 9 blz.

Onderzoeksoutput

Open Access

Bestand

11 Citaten (Scopus)

52 Downloads (Pure)

Lung cancer detection by electronic nose analysis of exhaled breath: a multi-center prospective external validation study

Buma, A. I. G., Muntinghe-Wagenaar, M. B., van der Noort, V., de Vries, R., Schuurbiers, M. M. F., Sterk, P. J., Schipper, S., Meurs, J., Cristescu, S. M., Hiltermann, T. J. N. & van den Heuvel, M. M., jul.-2025, In: Annals of Oncology. 36, 7, blz. 786-795 10 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

3 Citaten (Scopus)

6 Downloads (Pure)

Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Muntinghe-Wagenaar, B. B. & Hiltermann, T. J. N., 28-feb.-2025, In: Translational lung cancer research. 14, 2, blz. 328-333 6 blz.

Onderzoeksoutput: Editorial › Academic › peer review

Open Access

Bestand

53 Downloads (Pure)

Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients

Li, W., Zwierenga, F., Andini, K. D., Bucher, J. M., Scherpen, F., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., Kok, K. & Berg, A. V. D., apr.-2025, In: Cancers. 17, 7, 13 blz., 1090.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

24 Downloads (Pure)

Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment

Candido, W., Eggen, A. C., Jalving, M., Bosma, I., Horinga, R. D., van Heuvelen, K. C., Hiltermann, T. J. N., Oosting, S., Racz, E., van der Klauw, M. M., Reyners, A. K. L. & Nuver, J., 28-mrt.-2025, In: Journal for immunotherapy of cancer. 13, 3, 13 blz., e011168.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

25 Downloads (Pure)

Real-world 5-year survival outcomes with durvalumab after chemoradiotherapy in unresectable, stage III NSCLC: Final data extraction from PACIFIC-R

Girard, N., Bar, J., Daniel, C., Field, J., Fietkau, R., Garassino, M. C., Lopez, P. G., Haakensen, V. D., Hiltermann, J. T., Kao, S. C., McDonald, F., Mornex, F., Moskovitz, M. T., Peters, S., Siva, S., Solomon, B., Qiao, Y., Anand, S., Chander, P. & Filippi, A. R., mrt.-2025.

Onderzoeksoutput: Poster › Academic

Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy

Stoffers, R. H., Niezink, A. G. H., Chouvalova, O., Ubbels, J. F., Woltman-van Iersel, M., Hiltermann, T. J. N., Hijmering-Kappelle, L. B. M., Douma, G., De Hosson, S. M., Van Putten, J. W. G., Zandberg, F. T., Van Dijk, L. V., Langendijk, J. A. & Wijsman, R., 13-feb.-2025, In: ACTA ONCOLOGICA. 64, blz. 267-275 9 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

26 Downloads (Pure)

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer

Altan, M., Lopes, G., Hiltermann, T. J. N., Govindan, R., Villaruz, L. C., Calvo, E., Edelman, M. J., Furqan, M., Neal, J., Felip, E., Carlisle, J. W., Heymach, J. V., O'Cearbhaill, R. E., Zauderer, M., Chisamore, M., Corigliano, E., Eleftheriadou, I., Zajic, S., Jenkins, B. & Goodison, S. & 4 anderen, Suchindran, S., Ramos-Hernandez, N., Tarek, N. & Schoenfeld, A. J., 3-feb.-2025, In: Clinical Cancer Research. 31, 3, blz. 529-542 14 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

3 Citaten (Scopus)

17 Downloads (Pure)

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

DeLLphi-304 Investigators, Mountzios, G., Sun, L., Cho, B. C., Demirci, U., Baka, S., Gümüş, M., Lugini, A., Zhu, B., Yan, Y., Korantzis, I., Han, J.-Y., Ciuleanu, T. E., Ahn, M.-J., Rocha, P., Mazieres, J., Lau, S. C. M., Schuler, M., Blackhall, F. & Yoshida, T. & 7 anderen, Owonikoko, T. K., Paz-Ares, L., Jiang, T., Hamidi, A., Gauto, D., Recondo, G. & Rudin, C. M., 2-jun.-2025, In: New England Journal of Medicine. 12 blz.

Onderzoeksoutput › Academic › peer review

2024

128P - Whole blood transcriptomics identifies transcriptional patterns linked to outcomes in patients receiving immune checkpoint inhibitors

Hone Lopez, S., Loipfinger, S., Bhattacharya, A., Jalving, M., Oosting, S. F., Hiltermann, J., de Bruyn, M., de Vries, E. G. E., de Haan, J.-J. & Fehrmann, R., 14-sep.-2024, In: Annals of Oncology. 35, Supplement 2, blz. S266 1 blz.

Onderzoeksoutput: Meeting Abstract › Academic

AUTHOR CORRECTION to: “Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer” (ERJ Open Res 2022; 8: 00239-2022)

Gijtenbeek, R. G. P., van der Noort, V., Aerts, J. G. J. V., Staal-Van Den Brekel, J. A., Smit, E. F., Krouwels, F. H., Wilschut, F. A., Hiltermann, T. J. N., Timens, W., Schuuring, E., Janssen, J. D. J., Goosens, M., van den Berg, P. M., de Langen, A. J., Stigt, J. A., van den Borne, B. E. E. M., Groen, H. J. M., van Geffen, W. H. & van der Wekken, A. J., 1-jan.-2024, In: ERJ Open Research. 10, 1, 50239-2022.

Onderzoeksoutput: Erratum

Open Access

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

Kievit, H., Muntinghe-Wagenaar, M. B., Abdulahad, W. H., Rutgers, A., Hijmering-Kappelle, L. B. M., Hiddinga, B. I., Ubbels, J. F., Wijsman, R., van der Leij, M. J., Bijzet, J., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J., Kroesen, B.-J. & Hiltermann, T. J. N., 19-jul.-2024, In: Cancers. 16, 14, 12 blz., 2592.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

127 Downloads (Pure)

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

Muller, M., Best, M. G., van der Noort, V., Hiltermann, T. J. N., Niemeijer, A.-L. N., Post, E., Sol, N., In 't Veld, S. G. J. G., Nogarede, T., Visser, L., Schouten, R. D., van den Broek, D., Hummelink, K., Monkhorst, K., de Langen, A. J., Schuuring, E., Smit, E. F., Groen, H. J. M., Wurdinger, T. & van den Heuvel, M. M., 19-mrt.-2024, In: Tumor Biology. 46, 1, blz. S327-S340 14 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

2 Citaten (Scopus)

66 Downloads (Pure)

BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): Interim analysis (IA) of a randomized phase II study

Kalinka, E., Bahce, I., Navarro Mendivil, A. F., Ready, N., Chu, Q.-C., Sugawara, S., Sibille, A., Provencio Pulla, M., Johnson, M. L., Hiltermann, J. T. J. N., Ciuleanu, T.-E., Dziadziuszko, R., Santo, A., Zhang, Y., Liu, Y., Sarmiento, R., Tannenbaum-Dvir, S., Ojalvo, L., Wu, J. & O’Byrne, K. J., sep.-2024, In: Annals of Oncology. 35, Supplement 2, blz. S1061-S1062 2 blz.

Onderzoeksoutput: Meeting Abstract › Academic

Clinical outcomes with perioperative nivolumab (NIVO) by nodal status among patients (pts) with stage III resectable NSCLC: Results from the phase 3 CheckMate 77T study

Provencio, M., Awad, M. M., Spicer, J., Janssens, A., Moiseenko, F. V., Gao, Y., Watanabe, Y., Alexandru, A., Guisier, F., Frost, N., Franke, F. A., Hiltermann, T. J. N., He, J., Tanaka, F., Lu, S., Erdmann, C. C., Sathyanarayana, P., Tran, P., Devas, V. & Cascone, T., 5-jun.-2024, In: Journal of Clinical Oncology. 42, 17_suppl, LBA8007.

Onderzoeksoutput: Meeting Abstract › Academic

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

de Jager, V. D., Plomp, P., Paats, M. S., van Helvert, S., Elst, A. T., van den Berg, A., Dubbink, H. J., van Geffen, W. H., Zhang, L., Hendriks, L. E. L., Hiltermann, T. J. N., Hiddinga, B. I., Hijmering-Kappelle, L. B. M., Jalving, M., Kluiver, J., Koopman, B., van Kruchten, M., van der Logt, E. M. J., Piet, B. & van Putten, J. & 10 anderen, Reitsma, B. H., Rutgers, S. R., de Vries, M., Stigt, J. A., Groves, M. R., Timens, W., Willems, S. M., van Kempen, L. C., Schuuring, E. & van der Wekken, A. J., nov.-2024, In: ESMO Open. 9, 11, 12 blz., 103966.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

113 Downloads (Pure)

mRNA-1273 vaccination induces polyfunctional memory CD4 and CD8 T cell responses in patients with solid cancers undergoing immunotherapy or/and chemotherapy

Gangaev, A., van Sleen, Y., Brandhorst, N., Hoefakker, K., Prajapati, B., Singh, A., Boerma, A., van der Heiden, M., Oosting, S. F., van der Veldt, A. A. M., Hiltermann, T. J. N., GeurtsvanKessel, C. H., Dingemans, A.-M. C., Smit, E. F., de Vries, E. G. E., Haanen, J. B. A. G., Kvistborg, P. & van Baarle, D., aug.-2024, In: Frontiers in Immunology. 15, 13 blz., 1447555.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

2 Citaten (Scopus)

63 Downloads (Pure)

Ontwikkelingen in de oncologische systeembehandelingen

Hiltermann, T. J. N., Kleibeuker, E. A. & Smeele, I., 2024, Klachten na kanker: Praktisch handboek voor de eerste lijn. Stegmann, M. & Brandenbarg, D. (uitgave). Houten: Bohn, Stafleu, Van Loghum, blz. 9-19 11 blz.

Onderzoeksoutput: Chapter › Professional

Open Access

Bestand

21 Downloads (Pure)

Perioperative Nivolumab in Resectable Lung Cancer

CheckMate 77T Investigators, Cascone, T., Awad, M. M., Spicer, J. D., He, J., Lu, S., Sepesi, B., Tanaka, F., Taube, J. M., Cornelissen, R., Havel, L., Karaseva, N., Kuzdzal, J., Petruzelka, L. B., Wu, L., Pujol, J. L., Ito, H., Ciuleanu, T. E., De Oliveira Muniz Koch, L. & Janssens, A. & 10 anderen, Alexandru, A., Bohnet, S., Moiseyenko, F. V., Gao, Y., Watanabe, Y., Coronado Erdmann, C., Sathyanarayana, P., Meadows-Shropshire, S., Blum, S. I. & Provencio Pulla, M., 16-mei-2024, In: New England Journal of Medicine. 390, 19, blz. 1756-1769 14 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

185 Citaten (Scopus)

105 Downloads (Pure)

Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report

de Jager, V. D., van Kempen, L. C., Cajiao Garcia, B. N., Hiltermann, T. J. N., van der Wekken, A. J., Schuuring, E. & Willems, S. M., dec.-2024, In: JTO clinical and research reports. 5, 12, 6 blz., 100745.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

49 Downloads (Pure)

The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors

Horstman, I. M., Vinke, P. C., Suazo-Zepeda, E., Hiltermann, T. J. N., Heuvelmans, M. A., Corpeleijn, E. & de Bock, G. H., aug.-2024, In: Thoracic Cancer. 15, 23, blz. 1764-1771 8 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

73 Downloads (Pure)

The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy

Martin, M. V., Aguilar-Rosas, S., Franke, K., Pieterse, M., van Langelaar, J., Schreurs, R. R., Bijlsma, M. F., Besselink, M. G., Koster, J., Timens, W., Khasraw, M., Ashley, D. M., Keir, S. T., Ottensmeier, C. H., King, E. V., Verheij, J., Waasdorp, C., Valk, P. J. M., Engels, S. A. & Oostenbach, E. & 16 anderen, van Dinter, J. T., Hofman, D. A., Mok, J. Y., van Esch, W. J. E., Wilmink, H., Monkhorst, K., Verheul, H. M. W., Poel, D., Hiltermann, T. J. N., van Kempen, L. C., Groen, H. J., Aerts, J. G. J. V., van Heesch, S., Lowenberg, B., Plasterk, R. & Kloosterman, W. P., 4-jun.-2024, In: Cancer immunology research. 12, 6, blz. 759–778 20 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

4 Citaten (Scopus)

80 Downloads (Pure)

Trends in the prescription of immune checkpoint inhibitors for non-small cell lung cancer in the Netherlands from 2016 to 2020, a national cancer registry analysis

Suazo-Zepeda, E., Maas, W. J., Vinke, P. C., Hiltermann, T. N. J., Aarts, M. J., de Bock, G. H. & Heuvelmans, M. A., 30-sep.-2024, In: Translational lung cancer research. 13, 9, blz. 2202-2211 10 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

2 Citaten (Scopus)

66 Downloads (Pure)

2023

A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

Zwierenga, F., van Veggel, B. A. M. H., van den Berg, A., Groen, H. J. M., Zhang, L., Groves, M. R., Kok, K., Smit, E. F., Hiltermann, T. J. N., de Langen, A. J. & van der Wekken, A. J., nov.-2023, In: CANCER TREATMENT REVIEWS. 120, 10 blz., 102628.

Onderzoeksoutput: Review article › peer review

Open Access

Bestand

14 Citaten (Scopus)

190 Downloads (Pure)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Leest, P. V. D., Janning, M., Rifaela, N., Azpurua, M. L. A., Kropidlowski, J., Loges, S., Lozano, N., Sartori, A., Irwin, D., Lamy, P. J., Hiltermann, T. J. N., Groen, H. J. M., Pantel, K., Kempen, L. C. V., Wikman, H. & Schuuring, E., 29-aug.-2023, In: International Journal of Molecular Sciences. 24, 17, 14 blz., 13390.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

5 Citaten (Scopus)

124 Downloads (Pure)

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., Bhattacharya, A., van Binnendijk, R. S., GeurtsvanKessel, C. H., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M. & Rots, N. Y. & 3 anderen, van Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., aug.-2023, In: ESMO Open. 8, 4, 3 blz., 101599.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

2 Citaten (Scopus)

72 Downloads (Pure)

One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

van der Veldt, A. A. M., Oosting, S. F., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A. M. C., Smit, E. F., Hiltermann, T. J. N., Hartog, G. D., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M. & Rots, N. Y. & 3 anderen, van Baarle, D., Haanen, J. B. A. G. & de Vries, E. G. E., feb.-2023, In: ESMO Open. 8, 1, 2 blz., 100785.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

2 Citaten (Scopus)

111 Downloads (Pure)

Quality of life after treatment with immune checkpoint inhibitors for lung cancer: the impact of age

Suazo-Zepeda, E., Vinke, P. C., Heuvelmans, M. A., Sidorenkov, G., Hiltermann, T. J. N. & de Bock, G. H., feb.-2023, In: Lung Cancer. 176, blz. 89-97 9 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

7 Citaten (Scopus)

134 Downloads (Pure)

Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer

Donker, H. C., Cuppens, K., Froyen, G., Groen, H. J. M., Hiltermann, T. J. N., Maes, B., Schuuring, E., Volders, P. J., Lunter, G. A. & van Es, B., aug.-2023, In: Lung Cancer. 182, 7 blz., 107286.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

1 Citaat (Scopus)

112 Downloads (Pure)

Response to immune checkpoint inhibition is associated with the gut microbiome in advanced KRAS-mutated non-small cell lung cancer

Hiddinga, B. I., Bolte, L. A., van der Leest, P., Hijmering-Kappelle, L. B. M., van der Wekken, A. J., Schuuring, E., Gacesa, R., Hospers, G. A. P., Weersma, R. K., Björk, J. R. & Hiltermann, T. J. N., 30-okt.-2023, MedRxiv.

Onderzoeksoutput: Voordruk › Academic

Open Access

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial

Kievit, H., Muntinghe-Wagenaar, M. B., Hijmering-Kappelle, L. B. M., Hiddinga, B. I., Ubbels, J. F., Wijsman, R., Slingers, G., de Vries, R., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., apr.-2023, In: Lung Cancer. 178, blz. 96-102 7 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

4 Citaten (Scopus)

111 Downloads (Pure)

The additional diagnostic value of virtual bronchoscopy navigation in patients with pulmonary nodules: The NAVIGATOR study

Hiddinga, B. I., Slebos, D.-J., David Koster, T., Hijmering-Kappelle, L. B. M., Hiltermann, T. J. N., Kievit, H., van der Wekken, A. J., de Jonge, G., Vliegenthart, R., Van De Wauwer, C., Timens, W. & Bensch, F., mrt.-2023, In: Lung Cancer. 177, blz. 37-43 7 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

6 Citaten (Scopus)

180 Downloads (Pure)

Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study

Girard, N., Bar, J., Garrido, P., Garassino, M. C., McDonald, F., Mornex, F., Filippi, A. R., Smit, H. J. M., Peters, S., Field, J. K., Christoph, D. C., Sibille, A., Fietkau, R., Haakensen, V. D., Chouaid, C., Markman, B., Hiltermann, T. J. N., Taus, A., Sawyer, W. & Allen, A. & 3 anderen, Chander, P., Licour, M. & Solomon, B., feb.-2023, In: Journal of Thoracic Oncology. 18, 2, blz. 181-193 13 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

157 Citaten (Scopus)

208 Downloads (Pure)

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

Donker, H. C., van Es, B., Tamminga, M., Lunter, G. A., van Kempen, L. C. L. T., Schuuring, E., Hiltermann, T. J. N. & Groen, H. J. M., 21-apr.-2023, In: Scientific Reports. 13, 1, 10 blz., 6581.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

4 Citaten (Scopus)

141 Downloads (Pure)

2022

⁸⁹Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

Kok, I. C., Hooiveld, J. A., van de Donk, P. P., Giesen, D., van der Veen, E. L., Lub-de Hooge, M. N., Brouwers, A. H., Hiltermann, T. J. N., van der Wekken, A. J., Hijmering-Kappelle, L. B. M., Timens, W., Elias, S. G., Hospers, G. A. P., Groen, H. J. M., Uyterlinde, W., van der Hiel, B., Haanen, J. B., de Groot, D. J. A., Jalving, M. & de Vries, E. G. E., jan.-2022, In: Annals of Oncology. 33, 1, blz. 80-88 9 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

78 Citaten (Scopus)

212 Downloads (Pure)

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Koopman, B., Groen, H. J. M., Schuuring, E., Hiltermann, J., Timens, W., den Dunnen, W. F. A., van den Berg, A., ter Elst, A., van Kruchten, M., Kluiver, J., Hiddinga, B., Hijmering-Kappelle, L., Groves, M., Vilachá Madeira R Santos, J., van Kempen, L. & van der Wekken, A. J., mrt.-2022, In: Clinical lung cancer. 23, 2, blz. e104-e115 12 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

21 Citaten (Scopus)

178 Downloads (Pure)

A phase 1 study in patients with advanced non-small cell lung cancer treated with stereotactic radiotherapy to the primary tumor combined with durvalumab and tremelimumab

Kievit, H., Muntinghe-Wagenaar, M. B., Ubbels, F., Wijsman, R., Hijmering-Kappelle, L., Hiddinga, B., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., 1-jun.-2022, In: Journal of Clinical Oncology. 40, 16_suppl, blz. e21121-e21121 1 blz.

Onderzoeksoutput: Meeting Abstract › Academic

Detection and localization of early- and late-stage cancers using platelet RNA

In ’t Veld, S. G. J. G., Arkani, M., Post, E., Antunes-Ferreira, M., D'Ambrosi, S., Vessies, D. C. L., Vermunt, L., Vancura, A., Muller, M., Niemeijer, A. L. N., Tannous, J., Meijer, L. L., Le Large, T. Y. S., Mantini, G., Wondergem, N. E., Heinhuis, K. M., van Wilpe, S., Smits, A. J., Drees, E. E. E. & Roos, E. & 96 anderen, Leurs, C. E., Tjon Kon Fat, L. A., van der Lelij, E. J., Dwarshuis, G., Kamphuis, M. J., Visser, L. E., Harting, R., Gregory, A., Schweiger, M. W., Wedekind, L. E., Ramaker, J., Zwaan, K., Verschueren, H., Bahce, I., de Langen, A. J., Smit, E. F., van den Heuvel, M. M., Hartemink, K. J., Kuijpers, M. J. E., oude Egbrink, M. G. A., Griffioen, A. W., Rossel, R., Hiltermann, T. J. N., Lee-Lewandrowski, E., Lewandrowski, K. B., De Witt Hamer, P. C., Kouwenhoven, M., Reijneveld, J. C., Leenders, W. P. J., Hoeben, A., Verdonck-de Leeuw, I. M., Leemans, C. R., Baatenburg de Jong, R. J., Terhaard, C. H. J., Takes, R. P., Langendijk, J. A., de Jager, S. C., Kraaijeveld, A. O., Pasterkamp, G., Smits, M., Schalken, J. A., Łapińska-Szumczyk, S., Łojkowska, A., Żaczek, A. J., Lokhorst, H., van de Donk, N. W. C. J., Nijhof, I., Prins, H. J., Zijlstra, J. M., Idema, S., Baayen, J. C., Teunissen, C. E., Killestein, J., Besselink, M. G., Brammen, L., Bachleitner-Hofmann, T., Mateen, F., Plukker, J. T. M., Heger, M., de Mast, Q., Lisman, T., Pegtel, D. M., Bogaard, H. J., Jassem, J., Supernat, A., Mehra, N., Gerritsen, W., de Kroon, C. D., Lok, C. A. R., Piek, J. M. J., Steeghs, N., van Houdt, W. J., Brakenhoff, R. H., Sonke, G. S., Verheul, H. M., Giovannetti, E., Kazemier, G., Sabrkhany, S., Schuuring, E., Sistermans, E. A., Wolthuis, R., Meijers-Heijboer, H., Dorsman, J., Oudejans, C., Ylstra, B., Westerman, B. A., van den Broek, D., Koppers-Lalic, D., Wesseling, P., Nilsson, R. J. A., Vandertop, W. P., Noske, D. P., Tannous, B. A., Sol, N., Best, M. G. & Wurdinger, T., 12-sep.-2022, In: Cancer cell. 40, 9, blz. 999-1009.e6

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

83 Citaten (Scopus)

142 Downloads (Pure)

Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.

van der Leest, P., Hiddinga, B., Miedema, A., Azpurua, A. M. L., Rifaela, N., ter Elst, A., Timens, W., Groen, H. J. M., van Kempen, L. C. & Hiltermann, T. J. N., jan.-2022, In: Molecular oncology. 16, 1, blz. 310-310 1 blz.

Onderzoeksoutput

Open Access

Bestand

91 Downloads (Pure)

High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial

Zwierenga, F., van Veggel, B., Hendriks, L. E. L., Hiltermann, J. N., Hiddinga, B. I., Hijmering Kappelle, L. B. M., ter Elst, A., Hashemi, S. M. S., Dingemans, A.-M. C., van der Leest, C., de Langen, A. J., van den Heuvel, M. M. & van der Wekken, A. J., aug.-2022, In: Lung Cancer. 170, blz. 133-140 8 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

50 Citaten (Scopus)

211 Downloads (Pure)

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica

van der Geest, K. S. M., Sandovici, M., Rutgers, A., Hiltermann, T. J. N., Oosting, S. F., Slart, R. H. J. A. & Brouwer, E., 12-sep.-2022, In: Annals of the Rheumatic Diseases. 81, 2 blz., e210.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

13 Citaten (Scopus)

54 Downloads (Pure)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., GeurtsvanKessel, C. H., van Binnendijk, R. S., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., Bhattacharya, A., de Wilt, F., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., Rots, N. Y. & van Baarle, D. & 2 anderen, Haanen, J. B. A. G. & de Vries, E. G. E., jul.-2022, In: Lancet Oncology. 23, 7, blz. 833-835 3 blz.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

19 Citaten (Scopus)

100 Downloads (Pure)

Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival

Tamminga, M., Andree, K. C., van den Bos, H., Hiltermann, T. J. N., Mentink, A., Spierings, D. C. J., Lansdorp, P., Timens, W., Schuuring, E., Terstappen, L. W. M. M. & Groen, H. J. M., feb.-2022, In: British Journal of Cancer. 126, blz. 409–418 10 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

8 Citaten (Scopus)

94 Downloads (Pure)

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

DOCC Investigators, de Joode, K., Tol, J., Hamberg, P., Cloos, M., Kastelijn, E. A., Borgers, J. S. W., Nuij, V. J. A. A., Klaver, Y., Herder, G. J. M., Mutsaers, P. G. N. J., Dumoulin, D. W., Oomen-de Hoop, E., van Diemen, N. G. J., Libourel, E. J., Geraedts, E. J., Bootsma, G. P., van der Leest, C. H., Peerdeman, A. L. & Herbschleb, K. H. & 11 anderen, Visser, O. J., Bloemendal, H. J., van Laarhoven, H. W. M., de Vries, E. G. E., Hendriks, L. E. L., Beerepoot, L. V., Westgeest, H. M., van den Berkmortel, F. W. P. J., Haanen, J. B. A. G., Dingemans, A. M. C. & van der Veldt, A. A. M., jan.-2022, In: European Journal of Cancer. 160, blz. 261-272 12 blz.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

8 Citaten (Scopus)

98 Downloads (Pure)

Management of immune checkpoint inhibitor-induced polymyalgia rheumatica

van der Geest, K. S. M., Sandovici, M., Rutgers, A., Hiltermann, T. J. N., Oosting, S. F., Slart, R. H. J. A. & Brouwer, E., 10-nov.-2022, In: Annals of the Rheumatic Diseases. 81, 2 blz., e263.

Onderzoeksoutput › Academic › peer review

Open Access

Bestand

9 Citaten (Scopus)

88 Downloads (Pure)

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer

Gijtenbeek, R. G. P., van der Noort, V., Aerts, J. G. J. V., Staal-Van Den Brekel, J. A., Smit, E. F., Krouwels, F. H., Wilschut, F. A., Hiltermann, T. J. N., Timens, W., Schuuring, E., Janssen, J. D. J., Goosens, M., van den Berg, P. M., Joop de Langen, A., Stigt, J. A., van den Borne, B. E. E. M., Groen, H. J. M., van Geffen, W. H. & van der Wekken, A. J., 17-okt.-2022, In: ERJ Open Research. 8, 4, 9 blz., 00239-2022.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

10 Citaten (Scopus)

81 Downloads (Pure)

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment

Agbarya, A., Shalata, W., Addeo, A., Charpidou, A., Cuppens, K., Brustugun, O. T., Rajer, M., Jakopovic, M., Marinca, M., Pluzanski, A., Hiltermann, J. & Araujo, A., 21-mrt.-2022, In: Journal of Clinical Medicine. 11, 6, 16 blz., 1738.

Onderzoeksoutput: Article › Academic › peer review

Open Access

Bestand

9 Citaten (Scopus)

101 Downloads (Pure)

Jeroen Hiltermann

Onderzoeksoutput

Zoekresultaten